Raymond James & Associates I Rhythm Technologies, Inc. Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
A detailed history of Raymond James & Associates transactions in I Rhythm Technologies, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 2,441 shares of IRTC stock, worth $240,707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,441
Previous 2,456
0.61%
Holding current value
$240,707
Previous $262,000
8.02%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding IRTC
# of Institutions
278Shares Held
33.4MCall Options Held
226KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA2.95MShares$291 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.5MShares$246 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$241 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.14MShares$212 Million0.38% of portfolio
-
Sands Capital Management, LLC Arlington, VA2.14MShares$211 Million0.73% of portfolio
About iRhythm Technologies, Inc.
- Ticker IRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,026,600
- Market Cap $2.96B
- Description
- iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platf...